Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Invasive Group B Streptococcus Disease in Young Infants: a Pathway for the Evaluation & Licensure of an Investigational Maternal GBS Vaccine (Work Package 2)

NCT04653948 is registered in ClinicalTrials.gov with St George's, University of London as lead sponsor.

NCT NCT04653948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04653948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Invasive Group B Streptococcus Disease in Young Infants: a Pathway for the Evaluation & Licensure of an Investigational Maternal GBS Vaccine (Work Package 2)
Lead sponsor
St George's, University of London
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2019
Completion date
September 30, 2024
Enrollment
3,423 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

group b strep infection, group b streptococcal infection, early-onset, group b streptococcal infection, late-onset, group b streptococcus carrier in childbirth, group b streptococcus neonatal sepsis